To distinguish between these possibilities, we performed dynamic BH3 profiling (DBP) to analyze the dependence of A375M melanoma cells on each BCL-2 family member before and after treatment with BRAF or MEK inhibitors29. This evidence concerns the gene MAP2K7 and melanoma.